Antifungal Activity of Goniothalamin Enantiomers

Authors: Fatima, Angelo d.; Martins, Cleide Viviane B.u.z.a.n.e.l.l.o.; de Resende, Maria A.p.a.r.e.c.i.d.a.; Ferreira Magalhaes, Thais F.u.r.t.a.d.o.; Santiago Lima, Bruno H.e.n.r.i.q.u.e.; Watanabe, Gisele A.l.m.e.i.d.a.; Gois Ruiz, Ana L.T.; de Carvalho, Joao E.r.n.e.s.t.o.; Pilli, Ronaldo A.l.o.i.s.e.

Source: Letters in Drug Design & Discovery, Volume 5, Number 1, January 2008 , pp. 74-78(5)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $63.10 plus tax (Refund Policy)

Abstract:

A large number of human diseases are caused by fungus and the plant kingdom has proven to be a source of antifungal compounds. This work describes the in vitro activity of the natural product (R)-goniothalamin and its synthetic enantiomer, (S)-goniothalamin, against eleven strains of human pathogenic fungi. The minimum inhibitory concentration (MIC) values for both enantiomers were lower than 100 μg/mL for nine of the fungus strains studied. MIC values for both enantiomers against isolates of the dimorphic fungus Paracoccidioides braziliensis were in the range of 7-22 μg/mL. (R)- and (S)- goniothalamin were selective for the fungi strains presenting minimal toxic effects on mammalian kidney (Vero) and lung (V79) cell lines.

More about this publication?
  • Letters in Drug Design & Discovery publishes original letters on all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of Internet technology for both the submission and review of manuscripts. The journal is essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page